Recent Advances and Clinical Outcomes of Kidney Transplantation

• Format: eBook
• Language: English
• Published: Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2020
• Subjects: Medicine; acute humoral rejection; acute rejection; adaptive immune system; ADPKD; age; all-cause mortality; allograft survival; Alport syndrome; antibiotic resistance; antibody-mediated rejection (AMR); apoptosis; arsenic; atypical hemolytic uremic syndrome; autosomal dominant polycystic kidney disease; Belatacept; beliefs; biomarker; BK virus; BK virus nephropathy; BKV; BKVAN; branched chain amino acids; C/D ratio; C/D-ratio; C3d-binding assay; calcineurin inhibitor nephrotoxcity; calcineurin inhibitors; cancer; cancer mortality; cardiovascular high risk; cardiovascular mortality; CD45RC; children; creatinine; delayed graft function; diet; dietary intake; donor-specific antibodies (DSA); eculizumab; endothelial dysfunction; epidemiology; epidermal growth factor; ethnicity; fast tacrolimus metabolizers; first-line therapy; fish consumption; FK506; fluid management; genetic relationship donor/recipient; genomics; GFR; glomerulus; glucose intolerance; goal-directed fluid therapy; graft failure; graft survival; growth hormone; healthy subject; hospitalization; hyperchloremia; hyperoxaluria; hypomagnesaemia; hypothermic; hypoxic inducible factor; immunosuppression; inequity; infectious mortality; innate immune system; insulin resistance; insulin secretion; insulin-like growth factor 1; iron; iron deficiency; ischemia reperfusion injury; kidney; kidney allograft; kidney function; kidney graft dysfunction; kidney transplant; Kidney transplant; kidney transplant (KT); kidney transplant recipients; kidney transplantation; living donor; living donor kidney transplantation; living kidney donation; living-donor kidney transplantation; lymphocyte; machine perfusion; magnesium; malignancy; malondialdehyde; meta-analysis; methanogenesis; Methanosphaera stadtmanae; mortality; mucins; muscle mass; mycophenolic acid; n/a; N1-methyl-2-pyridone-5-carboxamide; N1-methylnicotinamide; native nephrectomy; necrosis; nephropathy; nephrotoxicity; new onset diabetes after renal transplantation; new-onset diabetes; niacin status; night-time renal transplantation; normothermic; obesity; opportunistic infection; oral glucose tolerance test; organ preservation; outcome; outcomes; oxalate; oxidative stress; oxidative stress.; patient outcome; patient survival; patient survival/outcome; perioperative complications; pharmacokinetic; pharmacokinetics; phylogeny; physical activity; plasmapheresis; polyomavirus; post-transplant diabetes mellitus; post-transplant malignancy; post-transplantation diabetes mellitus; posttransplant diarrhea; proteasome inhibitor; proton pump inhibitor; proton-pump inhibitors; renal cell carcinoma; renal transplant; renal transplant recipients; renal transplantation; renal transplantation.; single nucleotide polymorphisms; subarachnoid hemorrhage; sulfate-reducing bacteria; surgical complications; survival; systematic reviews; tacrolimus; tacrolimus metabolism; temperature; timing of removal; transplant; transplant recipients; transplant rejection; transplantation; tryptophan; UPEC; ureteric stent; urinary biomarkers; urinary excretion; urinary excretion of N1-methylnicotinamide; urinary tract infection; urological complications; Uropathogenic E. coli; virulence traits; vitamin B3; vitamin C; α-GST; π-GST
• Online Access: Open Access: DOAB: description of the publication; Open Access: DOAB, download the publication

 Advances in immunosuppression and kidney transplant techniques have led to significant improvements in the short-term survival of the renal allograft. Long-term graft survival, however, has relatively lagged behind and has now become one of the main problems in kidney transplantation. In this Special Issue, we discuss the recent research developments in kidney transplants that may affect long-term allografts, as well as the survival of the patient. The latest developments in living kidney donation are also explored.